Skip to main content

Advertisement

We are working on a new version of this page and we'd like your opinion. See an early preview or learn more.

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

  • Tanios Bekaii-Saab1, 2Email author,
  • Nita Williams4,
  • Christoph Plass4,
  • Miguel Villalona Calero1, 2 and
  • Charis Eng3, 4, 5
BMC Cancer20066:278

https://doi.org/10.1186/1471-2407-6-278

Received: 24 August 2006

Accepted: 06 December 2006

Published: 06 December 2006

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 Aug 2006 Submitted Original manuscript
20 Sep 2006 Reviewed Reviewer Report - Daphne Bell
20 Sep 2006 Reviewed Reviewer Report - Balazs Halmos
3 Oct 2006 Author responded Author comments - Tanios Bekaii-Saab
Resubmission - Version 2
3 Oct 2006 Submitted Manuscript version 2
6 Oct 2006 Reviewed Reviewer Report - Daphne Bell
7 Oct 2006 Reviewed Reviewer Report - Balazs Halmos
31 Oct 2006 Author responded Author comments - Tanios Bekaii-Saab
Resubmission - Version 3
31 Oct 2006 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
13 Nov 2006 Author responded Author comments - Tanios Bekaii-Saab
Resubmission - Version 5
13 Nov 2006 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
6 Dec 2006 Author responded Author comments - Tanios Bekaii-Saab
Resubmission - Version 7
6 Dec 2006 Submitted Manuscript version 7
Publishing
6 Dec 2006 Editorially accepted
6 Dec 2006 Article published 10.1186/1471-2407-6-278

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University
(2)
Department of Pharmacology, The Ohio State University
(3)
Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University
(4)
Department of Molecular Virology, Immunology and Medical Genetics; Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University
(5)
Genomic Medicine Institute and Taussig Cancer Center, Cleveland Clinic Foundation

Advertisement